Cardiovascular aspect of beta-thalassaemia

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 10, Issue 1, 2012, Pages 25-30

  Taksande, Amar ^a   Prabhu, Shakuntala ^b   Venkatesh, Sumitra ^b  

^a DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES   (India)

^b B J WADIA HOSPITAL FOR CHILDREN   (India)

Author keywords

Beta thalassemia; Cardiac function; Chelation therapy; Deferiprone; Desferrioxamine; Echocardiography; Endomyocardial biopsy; Heart; Iron; Liver iron concentrations; Magnetic resonance imaging; Thalassemic cardiomyopathy; Tissue doppler imaging

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FERRITIN; IRON; RADIOISOTOPE; SILDENAFIL; VERAPAMIL;

ANOREXIA; ARTICLE; BETA THALASSEMIA; CARDIOMEGALY; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CHELATION THERAPY; CLINICAL FEATURE; COMPLETE HEART BLOCK; CONGESTIVE HEART FAILURE; DIET; FERRITIN BLOOD LEVEL; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE BIOPSY; HEART PALPITATION; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; HOLTER MONITORING; HUMAN; IMAGING; IRON OVERLOAD; LIPID PEROXIDATION; PAROXYSMAL DYSPNEA; PATHOPHYSIOLOGY; PERICARDIAL EFFUSION; PHYSICAL ACTIVITY; PULMONARY HYPERTENSION; SCINTISCANNING; SINUS TACHYCARDIA; STRESS ECHOCARDIOGRAPHY; SUPERCONDUCTING QUANTUM INTERFERENCE DEVICE; SYNCOPE; THALASSEMIA MAJOR; THORAX PAIN; TISSUE DOPPLER IMAGING;

BETA-THALASSEMIA; CARDIOVASCULAR DISEASES; HUMANS; IRON OVERLOAD;

EID: 84857126837     PISSN: 18715257     EISSN: 18756182     Source Type: Journal    
DOI: 10.2174/187152512799201172     Document Type: Article

References (34)

1. Olivieri, N.F. The b-thalassemias. N. Engl. J. Med., 1999, 341, 99-109.
2. Rund, D.; Rachmilewitz, E. Beta Thalassemia. N. Engl. J. Med., 2005, 353, 1135-1146.
3. Dhawan S. In: Hemoglobinpathies. Sachdeva, A.; Lokeshwar, M.R.; Shah, N; Agrawal, B.R. Eds.; Jaypee Publisher: New Delhi, 2006; pp.169-176.
4. Aldouri, M.A.; Wonke, B.; Hoffbrand, A.V.; Flynn, D.M.; Ward, S.E.; Agnew, J.E.; Hilson A.J. High incidence of cardiomyopathy in beta-thalassemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol, 1990, 84, 113-117.
5. P.D. Evaluation of iron overload. Br. J. Haematol, 2004, 124, 697-711.
6. Hershko, C; Link, G.; Cabantchik, I. Pathophysiology of iron overload. Ann. N.Y. Acad. Sci., 1998, 50, 191-201.
7. E.J. Tissue iron overload and mechanisms of ironcatalyzed oxidative injury. Adv. Exp. Med. Biol, 1994, 366, 129-146.
8. Livrea, M.A.; Tesoriere, L.; Pintaudi, A.M. Oxidative stress and antioxidant status in p-thalassemia majoriron overload and depletion of lipid-soluble antioxidants. Blood, 1996, 88, 3608-3614.
9. Hahalis, G.; Alexopoulos, D.; Kremastinos, D.T.; Zoumbos, N.V. Heart failure in p-thalassemia syndromes: A decade of progress. Am. J. Med., 2005, 118, 957-967.
10. Aessopos, A.; Farmakis, D.; Hatziliami, A.; Fragodimitri, C; Karabatsos, F.; Joussef, J.; Mitilineou, E.; Diamanti-Kandaraki, E.; Meletis, J.; Karagiorga, M.J. Cardiac status in well-treated patients with thalassemia major. Eur. J. Haematol, 2004, 73, 359-366.
11. Lau, K.C.; Li, A.M.; Hui, P.W.; Yeung, C.Y. Left ventricular function in beta-thalassemia major. Arch. Dis. Child., 1989, 64, 1046-1051.
12. Grisaru, D.; Rachmilewitz, F.A.; Mosseri, M. Gotsman, M.; Lafair, J.S.; Okon, E.; Goldfarb, A.; Hasin, Y. Cardiopulmonary assessment in beta-thalassaemia major. Chest, 1990, 98, 1138-1142.
13. Jessup, M.; Manno, C.S. Diagnosis and management of iron-induced heart disease in Cooley's anemia. Ann. N.Y. Acad. Sci., 1998, 850, 242-250.
14. Gharzuddine, W.S.; Kazma, H.K.; Nuwayhid, I.A.; Bitar, F.F.; Koussa, S.F.; Moukarbel, G.V.; Tahir, A.T. Doppler characterization of left ventricular diastolic function in beta-thalassaemia major. Evidence for an early stage of impaired relaxation. Eur. J. Echocardiogr., 2002, 3, 47-51.
15. Aessopos, A.; Deftereos, S.; Tsironi, M.; Tsironi, M.; Karabatsos, F.; Yousef, J.; Fragodimitri, C.; Hatziliami, A.; Karagiorga, M. Predictive echo-Doppler indices of left ventricular impairment in B-thalassemic patients. Ann. Hematol., 2007, 86, 429-434.
16. Borgna-Pignatti, C.; Rigolotto, S.; Stefano; De Stefano, P.; Zhao, H.; Cappellini, M.D.; Del Vecchio, G.C.; Romeo, M.A.; Forni, G.L.; Gamberini, M.R.; Ghilardi, R.; Piga, A.; Cnaan, A. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica, 2004, 89, 1187-1193.
17. Moyssakis, I.; Tzanetea, R.; Tsaftaridis, P.; Rombos, I.; Papadopoulos, D.P.; Kalotychou, V.; Aessopos, A. Systolic and diastolic function in middle aged patients with sickle beta-thalassaemia. An echocardiographic study. Postgrad. Med. J., 2005, 81, 711-714.
18. Chrysohoou, C.; Greenberg, M.; Pitsavos, C.; Panagiotakos, D.B.; Ladis, V.; Barbetseas, J.; Brili, S.; Singh, S.; Stefanadis, C. Diastolic function in young patients with beta-thalassemia major: an echocardiographic study. Echocardiography, 2006, 23, 38-44.
19. Bosi, G.; Crepaz, R.; Gamberini, M.R.; Fortini, M.; Scarcia, S.; Bonsanate, E; Pitscheider, W.; Vaccari, M. Left ventricular remodeling, and systolic and diastolic function in young adults with b-thalassemia major: a doppler echocardiographic assessment and correlation with haematological data. Heart, 2003, 89, 762-766.
20. Vogel, M.; Anderson, L.J.; Holden, S.; Deanfield, J.E.; Pennell, D.J.; Walker, J.M. Tissue doppler echocardiography in patients with thalassemia detects early myocardial dysfunction related to myocardial iron overload. Eur. Heart. J., 2003, 24, 113-119.
21. Iarussi, D.; Di Salvo, G.; Pergola, V.; Coppolino, P.; Tedesco, M.A.; Ratti, G.; Esposito, L.; Calabrò, R.; Ferrara, M. Pulsed Doppler tissue imaging and myocardial function in thalassemia major. Heart Vessels., 2003, 18,1-6.
22. Liu, P.; Henkelman, M.; Joshi, J.; Hardy, P.; Butany, J.; Iwanochko, M.; Clauberg, M.; Dhar, M.; Mai, D.; Waien, S.; Olivieri, N.Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model. Can. J. Cardiol., 1996, 12, 155-164.
23. Johnston, D.L.; Rice, L.; Vick, G.W.; Hedrick, T.D.; Rokey, R. Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am. J. Med., 1989, 87, 40-47.
24. Papanikolaou, N.; Ghiatas, A.; Kattamis, A.; Ladis, C.; Kritikos, N.; Kattamis, C. Non-invasive myocardial iron assessment in thalassaemic patients. T2 relaxometry and magnetizationtransfer ratio measurements. Acta Radiol., 2000, 41, 348-351.
25. Anderson, L.J.; Holden, S.; Davis, B.; Prescott, E.; Charrier, C.C.; Bunce, N.H.; Firmin, D.N.; Wonke, B.; Porter, J.; Walker, J.M.; Pennell, D.J. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur. Heart. J., 2001, 22, 2171-2179.
26. Aessopos, A.; Berdoukas, V.; Tsironi, M. Prevention of Cardio-myopathy in Transfusion-Dependent Homozygous Thalassaemia Today and the Role of CardiacMagnetic Resonance Imaging. Adv. Hematol., 2009, 2009, 964897.
27. Tanner, M.A.; Galanello, R.; Dessi, C.; Westwood, M.A.; Smith, G.C.; Nair, S.V.; Anderson, L.J.; Walker, J.M.; Pennell, D.J. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J.Cardiovasc. Magn. Reson., 2006, 8, 543-547.
28. Fitchett, D.H.; Coltart, D.J.; Littler, W.A. Cardiac involvement in secondary hemochromatosisa catheter biopsy study and analysis of myocardium. Cardiovasc. Res., 1980,14, 719-724.
29. Olivieri, N.F.; Brittenham, G.M. Iron-chelating therapy and the treatment of thalassemia. Blood, 1997, 89, 739-761.
30. Ehlers, K.H.; Giardina, P.J.; Lesser, M.L.; Engle, M.A.; Hilgartner, M.W. Prolonged survival in patients with beta-thalassemia major treated with deferoxamine. J. Pediatr., 1991, 118, 540-545.
31. Wu, K.H.; Chang, J.S.; Tsai, C.H.; Peng, C.T. Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major. Ann. Hematol., 2004, 83, 471-473.
32. Daar, S.; Pathare, A.V. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload. Ann. Hematol., 2006, 85(5), 315-319.
33. Giardina, P.J.; Grady, R.W. Chelation therapy in beta thalassemia: The optimistic update. Semin. Hematol., 2001, 38, 360-366.
34. Borgna-Pignatti, C.; Rugolotto, S.; De Stefano, P.; Piga, A.; Di Gregorio, F.; Gamberini, M.R.; Sabato, V.; Melevendi, C.; Cappellini, M.D.; Verlato, G. Survival and disease complications in thalassemia major. Ann. N. Y. Acad. Sci., 1998, 850, 227-230.